plerixafor has been researched along with Disease Exacerbation in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; Feng, X; Liu, X; Ren, Q; Wang, H; Wang, L; Wang, R; Yang, F; Yang, X; Zhang, D; Zhang, Y; Zheng, G | 1 |
| Fang, Q; Liu, P; Ma, D; Ni, M; Pan, C; Wang, J; Zhang, S | 1 |
| Ackerman, JJH; Beeman, SC; Duan, C; Engelbach, JA; Garbow, JR; Ge, X; Perez-Torres, CJ; Rich, KM; Tsien, CI; Yang, R; Yuan, L | 1 |
| Craig, M; Cumpston, A; Hamadani, M; Kanate, AS; Watkins, K | 1 |
| Alcoceba, M; Blanco, O; Bosch, R; Casanova, I; Céspedes, MV; Dieguez-Gonzalez, R; Gallardo, A; Gonzalez-Díaz, M; Grañena, A; Mangues, R; Moreno, MJ; Mozos, A; Novelli, S; Pavón, MÁ; Sierra, J | 1 |
| Boucard, C; Chinot, O; Delfino, C; Denicolai, E; Figarella-Branger, D; Graillon, T; Metellus, P; Nanni, I; Ouafik, L; Padovani, L; Tabouret, E; Tchoghandjian, A | 1 |
| Chen, Y; Chern, GG; Chiang, T; Gao, DY; Lin, TT; Liu, CH; Liu, JY | 1 |
| Gao, C; Guo, F; Teng, F; Tian, WY; Wang, YM; Xue, FX; Zhang, YF; Zhao, J | 1 |
| Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R | 1 |
| Chan, KM; Chen, Y; Chern, GG; Chiang, T; Hsu, FF; Liu, CH; Liu, JY; Liu, YC; Wu, YH | 1 |
| Bachmann, S; Chander, P; Goligorsky, MS; Jasmin, JF; Lisanti, MP; Park, HC; Ratliff, B; Sharkovska, Y; Stoessel, A; Yamamoto, I; Yasuda, K | 1 |
| Chen, Y; Feng, GS; Fu, J; He, YQ; Li, YQ; Li, Z; Lin, Y; Liu, Q; Tang, L; Wang, C; Wang, HY; Wu, FQ; Wu, MC; Yan, HX; Yang, W; Yu, LX; Zhang, HL; Zheng, LY; Zou, SS | 1 |
| Hajishengallis, G; McIntosh, ML | 1 |
1 trial(s) available for plerixafor and Disease Exacerbation
12 other study(ies) available for plerixafor and Disease Exacerbation
| Article | Year |
|---|---|
Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
Topics: Adolescent; Adoptive Transfer; Animals; Antineoplastic Agents, Immunological; Benzylamines; Bone Marrow; Cell Movement; Chemokine CCL3; Chemokine CXCL12; Child; Child, Preschool; Cyclams; Disease Models, Animal; Disease Progression; Female; Forkhead Transcription Factors; Gene Expression Regulation, Leukemic; Gene Knock-In Techniques; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Maraviroc; Mice; Mice, Transgenic; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Receptors, CCR; Signal Transduction; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2020 |
Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
Topics: Benzylamines; Cancer-Associated Fibroblasts; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Disease Progression; Humans; Mesenchymal Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrroles; Receptors, CXCR4; Signal Transduction; Transforming Growth Factor beta; Tumor Microenvironment | 2020 |
Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain.
Topics: Animals; Benzylamines; Brain; Cyclams; Disease Models, Animal; Disease Progression; Female; Heterocyclic Compounds; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Necrosis; Radiation Injuries, Experimental; Receptors, CXCR4; Topotecan | 2018 |
Salvage bone marrow harvest in patients failing plerixafor-based stem cell mobilization attempt: feasibility and autologous transplantation outcomes.
Topics: Aged; Antigens, CD34; Benzylamines; Blood Platelets; Bone Marrow Cells; Cyclams; Disease Progression; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Failure | 2013 |
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.
Topics: Animals; Benzylamines; Cell Line, Tumor; Cell Movement; Cyclams; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; In Vitro Techniques; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Invasiveness; Prognosis; Receptors, CXCR4; Survival Rate; Xenograft Model Antitumor Assays | 2015 |
Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Benzylamines; Brain Neoplasms; Chemokine CXCL12; Chemoradiotherapy; Child; Child, Preschool; Cyclams; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Gene Expression Profiling; Glioblastoma; Heterocyclic Compounds; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Proportional Hazards Models; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Retrospective Studies; Signal Transduction; Temozolomide; Time Factors; Tissue Culture Techniques; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2; Young Adult | 2015 |
Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Disease Progression; Genetic Therapy; Heterocyclic Compounds; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Sorafenib; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2015 |
Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
Topics: Animals; Benzylamines; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Coculture Techniques; Cyclams; Cytokines; Disease Progression; Endometrial Neoplasms; Female; Fibroblasts; Heterocyclic Compounds; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Mice, Nude; Prognosis; Receptors, CXCR4; Signal Transduction; Transplantation, Heterologous; Tumor Burden | 2016 |
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cyclams; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neovascularization, Pathologic; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted.
Topics: Animals; Benzylamines; Caveolin 1; Cell Division; Chemokine CXCL12; Cyclams; Disease Progression; Enzyme Inhibitors; Fibrosis; Hematopoietic Stem Cells; Heterocyclic Compounds; Kidney; Kidney Cortex; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; omega-N-Methylarginine; Receptors, CXCR4; Recovery of Function; Regeneration; Stem Cells; Ureteral Obstruction | 2010 |
OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
Topics: AC133 Antigen; Animals; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Benzylamines; Carcinoma, Hepatocellular; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Disease Progression; Disease-Free Survival; Epithelial Cell Adhesion Molecule; Female; Gene Knockdown Techniques; Glycoproteins; Heterocyclic Compounds; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplastic Stem Cells; Peptides; Prognosis; Receptors, CXCR4; RNA, Small Interfering; Spheroids, Cellular | 2012 |
Inhibition of Porphyromonas gingivalis-induced periodontal bone loss by CXCR4 antagonist treatment.
Topics: Alveolar Bone Loss; Animals; Anti-Bacterial Agents; Bacterial Load; Bacteroidaceae Infections; Benzylamines; Cyclams; Disease Models, Animal; Disease Progression; Heterocyclic Compounds; Infusion Pumps, Implantable; Mice; Mice, Inbred BALB C; Periodontitis; Porphyromonas gingivalis; Real-Time Polymerase Chain Reaction; Receptors, CXCR4 | 2012 |